Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai No. 3 Pharmaceutical Factory was a foundational state-owned pharmaceutical enterprise in China, established in 1950 and based in Shanghai. The company is historically significant for being the first in China to successfully mass-produce penicillin, significantly advancing the country's healthcare capabilities during the mid-20th century. Throughout its history, it specialized in the research, development, and large-scale manufacturing of antibiotics, including streptomycin and various cephalosporins. Following the restructuring of the Chinese pharmaceutical industry, the factory was integrated into Shanghai Pharmaceuticals Holding (SPH). It now operates as part of SPH's core manufacturing infrastructure, maintaining a focus on high-quality anti-infective medications and active pharmaceutical ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on No. 3 Chinese Pharmaceutical Factory.